Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03104959 · ClinicalTrials.gov registry record · NA

Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol

A NA study, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.

Terminated
Registry status
NA
Development phase
200
Enrollment target

NCT03104959: Clinical Trial NA study, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.

NCT03104959 is a NA study that was terminated before completion, run by St. Luke's Hospital and Health Network, Pennsylvania. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03104959, a NA study, was terminated before completion, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.

TERMINATED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

This is a double-blinded study involving healthy non-alcoholic (self-reported) volunteers over the age of 21. Consent is obtained prior to participation in the study while the participant is sober. Volunteers are recruited from residency programs, hospital employees, emergency medical personnel, and friends of the study investigators. If the volunteers choose to drink, they can participate in the study the night of ingestion of alcohol. There is no amount we ask them to drink, and we allow them to withdraw from the study at any time. We never force them to drink alcohol, or even encourage it. The participation is completely voluntary, if they would like to participate and if they choose to drink alcohol, we ask them to participate in the placebo controlled study in the safety of their own home. Then materials for the study are given out prior to their participation. An envelope is given with the questionnaire, and a small packet containing 3 pills of either NAC or placebo, and a small smear of Vicks vapor rub concealed in a small packet. At the end of their alcohol ingestion, the volunteer is asked to estimate the number roof drinks consumed and take 1 capsule per 3 drinks consumed of either 600 mg N-Acetyl-L-Cysteine or placebo capsules. In the morning, each participant fills out a Hangover Symptom Score questionnaire . A random number generator is used to determine placebo or NAC first, then the participant is given the other treatment at their subsequent encounter. Then study is being conducted over a series of many months, and data can be analyzed by the hangover symptoms scale data when using NAC compared to placebo. The data will be analyzed using the numerical values of each category for hangover classification and compare the placebo data to the control data.

Interventions

  • OTHER placebo
  • DIETARY_SUPPLEMENT N-acetyl cysteine

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2016-01
Est. Completion 2018-06-06
Phase NA

Why NCT03104959 stopped before completion

NCT03104959 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT03104959 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03104959 about?

NCT03104959 is a clinical study titled "Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol". This is a double-blinded study involving healthy non-alcoholic (self-reported) volunteers over the age of 21. Consent is obtained prior to participation in the study while the participant is sober. Volunteers are recruited from residency programs, hospital employees, emergency medical personnel, and...

What is the current status of trial NCT03104959?

This trial is currently terminated. It is a NA study. The enrollment target is 200 participants. The study started on 2016-01. Estimated completion is 2018-06-06.

What interventions are being tested in trial NCT03104959?

The interventions under investigation include: placebo (OTHER), N-acetyl cysteine (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03104959?

This trial is sponsored by St. Luke's Hospital and Health Network, Pennsylvania, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03104959's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03104959, the US trial registry maintained by the National Library of Medicine. NCT03104959 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.